U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Fallopian Tube Carcinoma

MedGen UID:
857332
•Concept ID:
C3897738
•
Neoplastic Process

Definition

The reemergence of fallopian tube carcinoma after a period of remission. [from NCI]

Professional guidelines

PubMed

Integrating antibody drug conjugates in the management of gynecologic cancers.
Chelariu-Raicu A, Mahner S, Moore KN, Lorusso D, Coleman RL
Int J Gynecol Cancer 2023 Mar 6;33(3):420-429. doi: 10.1136/ijgc-2022-003701. PMID: 36878560
Frontline Maintenance Treatment for Ovarian Cancer.
Elyashiv O, Wong YNS, Ledermann JA
Curr Oncol Rep 2021 Jun 14;23(8):97. doi: 10.1007/s11912-021-01088-w. PMID: 34125335Free PMC Article
Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer.
Webber K, Friedlander M
Best Pract Res Clin Obstet Gynaecol 2017 May;41:126-138. Epub 2016 Nov 23 doi: 10.1016/j.bpobgyn.2016.11.004. PMID: 28027849

Recent clinical studies

Diagnosis

PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma.
Patel PV, Cohade C, Chin BB
Gynecol Oncol 2002 Dec;87(3):323-6. doi: 10.1006/gyno.2002.6841. PMID: 12468334
Recurrent fallopian tube carcinoma: TP53 mutation and clinical course.
Hellström AC, Blegen H, Malec M, Silfverswärd C, Lystad S, Børresen-Dale AL, Auer G
Int J Gynecol Pathol 2000 Apr;19(2):145-51. doi: 10.1097/00004347-200004000-00008. PMID: 10782411

Therapy

Recurrent fallopian tube carcinoma: TP53 mutation and clinical course.
Hellström AC, Blegen H, Malec M, Silfverswärd C, Lystad S, Børresen-Dale AL, Auer G
Int J Gynecol Pathol 2000 Apr;19(2):145-51. doi: 10.1097/00004347-200004000-00008. PMID: 10782411
Complete response to topotecan of recurrent fallopian tube carcinoma.
Dunton CJ, Neufeld J
Gynecol Oncol 2000 Jan;76(1):128-9. doi: 10.1006/gyno.1999.5630. PMID: 10620456
Primary carcinoma of the fallopian tube: favourable response to new chemotherapeutic agent, CHIP.
Wong WS, Tindall VR, Wagstaff J, Bramwell V, Crowther D
J R Soc Med 1985 Mar;78(3):203-6. doi: 10.1177/014107688507800306. PMID: 3973884Free PMC Article

Prognosis

Recurrent fallopian tube carcinoma: TP53 mutation and clinical course.
Hellström AC, Blegen H, Malec M, Silfverswärd C, Lystad S, Børresen-Dale AL, Auer G
Int J Gynecol Pathol 2000 Apr;19(2):145-51. doi: 10.1097/00004347-200004000-00008. PMID: 10782411

Clinical prediction guides

Recurrent fallopian tube carcinoma: TP53 mutation and clinical course.
Hellström AC, Blegen H, Malec M, Silfverswärd C, Lystad S, Børresen-Dale AL, Auer G
Int J Gynecol Pathol 2000 Apr;19(2):145-51. doi: 10.1097/00004347-200004000-00008. PMID: 10782411

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...